M G Seneviratne1, S M Grieve2, G A Figtree3, R Garsia4, D S Celermajer5, S Adelstein4, R Puranik6. 1. Sydney Medical School, The University of Sydney, Sydney, Australia martin.seneviratne@sswahs.nsw.gov.au. 2. Sydney Medical School, The University of Sydney, Sydney, Australia Department of Radiology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia Heart Research Institute, Newtown, NSW, Australia. 3. Sydney Medical School, The University of Sydney, Sydney, Australia Department of Cardiology, Royal North Shore Hospital, St Leonards, NSW, Australia. 4. Sydney Medical School, The University of Sydney, Sydney, Australia Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. 5. Sydney Medical School, The University of Sydney, Sydney, Australia Heart Research Institute, Newtown, NSW, Australia Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. 6. Sydney Medical School, The University of Sydney, Sydney, Australia Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
Abstract
OBJECTIVES: To assess the prevalence, distribution and clinical correlates of myocardial fibrosis, as detected by cardiac magnetic resonance (CMR), in systemic lupus erythematosus (SLE). METHODS: Forty-one subjects (average age 39 ± 12 years and 80% female) with SLE underwent CMR imaging at 1.5T, using late gadolinium enhancement (LGE) to quantify the area of myocardial fibrosis in the left ventricle (LV). Subjects also underwent transthoracic echocardiography (TTE) and exercise testing. RESULTS: LGE was detected in 15/41 subjects, 11 with localized LGE (<15% LV mass) and four with extensive LGE (>15% LV mass). The commonest site of LGE was the interventricular septum, with all but one case demonstrating an intramural or inflammatory pattern. The mean age of the >15% LGE group (55 ± 15 years) was significantly higher than the <15% or absent LGE subgroups. Based on both CMR and TTE measurements, subjects with LGE > 15% demonstrated a reduced E/A ratio of 0.9 ± 0.4 relative to the <15% and absent LGE subgroups. LV end-systolic volume (ESVi), end-diastolic volume (EDVi) and maximum exercise capacity were also reduced in the >15% LGE group. CONCLUSIONS: Mid-wall myocardial fibrosis occurs frequently in SLE and is strongly associated with advancing subject age, but not with SLE duration or severity. Extensive LGE may be associated with diastolic dysfunction and impaired exercise capacity, although this may be an epiphenomenon of age. Cardiac magnetic resonance with quantitative assessment of LGE may provide a basis for cardiac risk stratification in SLE.
OBJECTIVES: To assess the prevalence, distribution and clinical correlates of myocardial fibrosis, as detected by cardiac magnetic resonance (CMR), in systemic lupus erythematosus (SLE). METHODS: Forty-one subjects (average age 39 ± 12 years and 80% female) with SLE underwent CMR imaging at 1.5T, using late gadolinium enhancement (LGE) to quantify the area of myocardial fibrosis in the left ventricle (LV). Subjects also underwent transthoracic echocardiography (TTE) and exercise testing. RESULTS: LGE was detected in 15/41 subjects, 11 with localized LGE (<15% LV mass) and four with extensive LGE (>15% LV mass). The commonest site of LGE was the interventricular septum, with all but one case demonstrating an intramural or inflammatory pattern. The mean age of the >15% LGE group (55 ± 15 years) was significantly higher than the <15% or absent LGE subgroups. Based on both CMR and TTE measurements, subjects with LGE > 15% demonstrated a reduced E/A ratio of 0.9 ± 0.4 relative to the <15% and absent LGE subgroups. LV end-systolic volume (ESVi), end-diastolic volume (EDVi) and maximum exercise capacity were also reduced in the >15% LGE group. CONCLUSIONS: Mid-wall myocardial fibrosis occurs frequently in SLE and is strongly associated with advancing subject age, but not with SLE duration or severity. Extensive LGE may be associated with diastolic dysfunction and impaired exercise capacity, although this may be an epiphenomenon of age. Cardiac magnetic resonance with quantitative assessment of LGE may provide a basis for cardiac risk stratification in SLE.
Authors: P Stefan Biesbroek; Sjoerd C Heslinga; Peter M van de Ven; Mike J L Peters; Raquel P Amier; Thelma C Konings; Christopher D Maroules; Colby Ayers; Parag H Joshi; Irene E van der Horst-Bruinsma; Vokko P van Halm; Albert C van Rossum; Michael T Nurmohamed; Robin Nijveldt Journal: Clin Rheumatol Date: 2018-05-12 Impact factor: 2.980
Authors: Thilo Burkard; Marten Trendelenburg; Thomas Daikeler; Christoph Hess; Jens Bremerich; Philip Haaf; Peter Buser; Michael J Zellweger Journal: PLoS One Date: 2018-10-01 Impact factor: 3.240
Authors: Chiara Bucciarelli-Ducci; Ellen Ostenfeld; Lauren A Baldassarre; Vanessa M Ferreira; Luba Frank; Kimberly Kallianos; Subha V Raman; Monvadi B Srichai; Elisa McAlindon; Sophie Mavrogeni; Ntobeko A B Ntusi; Jeanette Schulz-Menger; Anne Marie Valente; Karen G Ordovas Journal: J Cardiovasc Magn Reson Date: 2020-09-28 Impact factor: 5.364